Bone Therapeutics's total assets for Q4 2024 were €4.74M, a decrease of -49.53% from the previous quarter. GB:0R55 total liabilities were €31.55M for the fiscal quarter, a 5.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.